E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/3/2006 in the Prospect News Biotech Daily.

Jefferies suspends rating for SFBC

SFBC International Inc.'s rating was suspended by Jefferies & Co., Inc. analyst David Windley based on the lack of numbers provided by SFBC management. Jefferies is suspending its rating pending "greater visibility into the impairment and guidance issues raised in last night's inadequate press release." SFBC delayed its release instead of providing the expected fourth-quarter and full-year 2005 results. Shares of the Miami, Fla., drug development services company were down $3.58, or 16.06%, at $18.71 on volume of 9,040,091 shares versus the three-month running average of 2,208,560 shares. (Nasdaq: SFCC)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.